{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:49:44Z","timestamp":1792727384105,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T00:00:00Z","timestamp":1348012800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s00467-012-2305-7","type":"journal-article","created":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T14:22:48Z","timestamp":1347978168000},"page":"1749-1755","source":"Crossref","is-referenced-by-count":21,"title":["Angiogenesis and autosomal dominant polycystic kidney disease"],"prefix":"10.1007","volume":"28","author":[{"given":"Jennifer L.","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian S.","family":"Woolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,19]]},"reference":[{"key":"2305_CR1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","volume":"60","author":"PC Harris","year":"2009","unstructured":"Harris PC, Torres VE (2009) Polycystic kidney disease. Annu Rev Med 60:321\u2013327","journal-title":"Annu Rev Med"},{"key":"2305_CR2","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00467-010-1617-8","volume":"25","author":"D Mekahli","year":"2010","unstructured":"Mekahli D, Woolf AS, Bockenhauer D (2010) Similar renal outcomes in children with ADPKD diagnosed by screening or presenting with symptoms. Pediatr Nephrol 25:2275\u20132282","journal-title":"Pediatr Nephrol"},{"key":"2305_CR3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.pathol.2.010506.091850","volume":"2","author":"PD Wilson","year":"2007","unstructured":"Wilson PD, Goilav B (2007) Cystic disease of the kidney. Annu Rev Pathol 2:341\u2013368","journal-title":"Annu Rev Pathol"},{"key":"2305_CR4","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.gastro.2006.12.039","volume":"132","author":"TV Masyuk","year":"2007","unstructured":"Masyuk TV, Masyuk AI, Torres VE, Harris PC, Larusso NF (2007) Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3\u2019,5-cyclic monophosphate. Gastroenterology 132:1104\u20131116","journal-title":"Gastroenterology"},{"key":"2305_CR5","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","volume":"9","author":"VH Gattone","year":"2003","unstructured":"Gattone VH, Wang X, Harris PC, Torres VC (2003) Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 9:1323\u20131326","journal-title":"Nat Med"},{"key":"2305_CR6","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","volume":"103","author":"JM Shillingford","year":"2006","unstructured":"Shillingford JM, Murcia NS, Larson CH, Low SH, Hedgepeth R, Brown N, Flask CA, Novick AC, Goldfarb DA, Kramer-Zucker A, Walz G, Piontek KB, Germino GG, Weimbs T (2006) The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci U S A 103:5466\u20135471","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2305_CR7","doi-asserted-by":"crossref","first-page":"c25","DOI":"10.1159\/000334166","volume":"120","author":"MY Chang","year":"2012","unstructured":"Chang MY, Ong AC (2012) Mechanism-based therapeutics for autosomal dominant polycystic kidney disease: recent progress and future prospects. Nephron Clin Pract 120:c25\u2013c34","journal-title":"Nephron Clin Pract"},{"key":"2305_CR8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2006010086","volume":"18","author":"AN Nguyen","year":"2007","unstructured":"Nguyen AN, Wallace DP, Blanco G (2007) Ouabain binds with high affinity to the Na, K-ATPase in human polycystic kidney cells and induces extracellular signal-regulated kinase activation and proliferation. J Am Soc Nephrol 18:46\u201357","journal-title":"J Am Soc Nephrol"},{"key":"2305_CR9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1523-1755.2001.00768.x","volume":"60","author":"E Bello-Reuss","year":"2001","unstructured":"Bello-Reuss E, Holubec K, Rajaraman S (2001) Angiogenesis in autosomal dominant polycystic kidney disease. Kidney Int 60:37\u201345","journal-title":"Kidney Int"},{"key":"2305_CR10","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.ki.5001725","volume":"70","author":"W Wei","year":"2006","unstructured":"Wei W, Popov V, Walocha JA, Wen J, Bello-Reuss E (2006) Evidence of angiogenesis and microvascular regression in autosomal-dominant polycystic kidney disease kidneys: a corrosion case study. Kidney Int 70:1261\u20131268","journal-title":"Kidney Int"},{"key":"2305_CR11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrneph.2011.219","volume":"9","author":"DA Long","year":"2012","unstructured":"Long DA, Norman JT, Fine LG (2012) Restoring the renal microvasculature to treat chronic kidney disease. Nat Rev Nephrol 9:244\u2013250","journal-title":"Nat Rev Nephrol"},{"key":"2305_CR12","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1073\/pnas.040550097","volume":"97","author":"K Kim","year":"2000","unstructured":"Kim K, Drummond I, Ibraghimov-Beskrovnaya O, Klinger K, Arnaout MA (2000) Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci U S A 97:1731\u20131736","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2305_CR13","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0002-9440(10)65428-4","volume":"154","author":"AC Ong","year":"1999","unstructured":"Ong AC, Ward CJ, Butler RJ, Biddolph S, Bowker C, Torra R, Pei Y, Harris PC (1999) Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue. Am J Pathol 154:1721\u20131729","journal-title":"Am J Pathol"},{"key":"2305_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1681\/ASN.V1211","volume":"12","author":"VE Torres","year":"2001","unstructured":"Torres VE, Cai Y, Chen X, Wu GQ, Geng L, Cleghorn KA, Johnson CM, Somlo S (2001) Vascular expression of polycystin-2. J Am Soc Nephrol 12:1\u20139","journal-title":"J Am Soc Nephrol"},{"key":"2305_CR15","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/CIRCULATIONAHA.107.710111","volume":"117","author":"SM Nauli","year":"2008","unstructured":"Nauli SM, Kawanabe Y, Kaminski JJ, Pearce WJ, Ingber DE, Zhou J (2008) Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1. Circulation 117:1161\u20131171","journal-title":"Circulation"},{"key":"2305_CR16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/CIRCRESAHA.108.192765","volume":"104","author":"WA AbouAlaiwi","year":"2009","unstructured":"AbouAlaiwi WA, Takahashi M, Mell BR, Jones TJ, Ratnam S, Kolb RJ, Nauli SM (2009) Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signalling cascades. Circ Res 104:860\u2013869","journal-title":"Circ Res"},{"key":"2305_CR17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/labinvest.2010.159","volume":"91","author":"S Hassane","year":"2011","unstructured":"Hassane S, Claij N, Jodar M, Dedman A, Lauritzen I, Duprat F, Koendermann JS, van der Wal A, Breuning MH, de Heer E, Honore E, DeRuiter MC, Peters DJ (2011) Pkd1-inactivation in vascular smooth muscle cells and adaptation to hypertension. Lab Investig 91:24\u201332","journal-title":"Lab Investig"},{"key":"2305_CR18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ceb.2008.12.012","volume":"21","author":"M Lohela","year":"2009","unstructured":"Lohela M, Bry M, Tammela T, Alitalo K (2009) VEGFs and receptors involved in angiogenesis versus lymphiangiogenesis. Curr Opin Cell Biol 21:154\u2013165","journal-title":"Curr Opin Cell Biol"},{"key":"2305_CR19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1681\/ASN.2008020243","volume":"20","author":"AS Woolf","year":"2009","unstructured":"Woolf AS, Gnudi L, Long DA (2009) Roles of angiopoietins in kidney development and disease. J Am Soc Nephrol 20:239\u2013244","journal-title":"J Am Soc Nephrol"},{"key":"2305_CR20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1091\/mbc.E09-07-0590","volume":"21","author":"N Ferrara","year":"2010","unstructured":"Ferrara N (2010) Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action. Mol Biol Cell 21:687\u2013690","journal-title":"Mol Biol Cell"},{"key":"2305_CR21","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nrc2505","volume":"8","author":"SJ Harper","year":"2008","unstructured":"Harper SJ, Bates DO (2008) VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer 8:880\u2013887","journal-title":"Nat Rev Cancer"},{"key":"2305_CR22","doi-asserted-by":"crossref","first-page":"20126","DOI":"10.1074\/jbc.M500292200","volume":"280","author":"KT Kim","year":"2005","unstructured":"Kim KT, Choi HH, Steinmetz MO, Maco B, Kammerer RA, Ahn SY, Kim HZ, Lee GM, Koh GY (2005) Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2. J Biol Chem 280:20126\u201320131","journal-title":"J Biol Chem"},{"key":"2305_CR23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","volume":"277","author":"PC Maisonpierre","year":"1997","unstructured":"Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulous N, Daly TJ, Davis S, Sato TN, Yancopoulos GD (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55\u201360","journal-title":"Science"},{"key":"2305_CR24","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI58832","volume":"122","author":"M Felcht","year":"2012","unstructured":"Felcht M, Luck R, Schering A, Seidel P, Srivastava K, Hu J, Bartol A, Kienast Y, Vettel C, Loos EK, Kutschera S, Bartels S, Appak S, Besemfelder E, Terhardt D, Chavakis E, Wieland T, Klein C, Thomas M, Uemura A, Goerdt S, Augustin HG (2012) Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling. J Clin Invest 122:1991\u20132005","journal-title":"J Clin Invest"},{"key":"2305_CR25","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/j.1523-1755.2005.00589.x","volume":"68","author":"KD Stringer","year":"2005","unstructured":"Stringer KD, Komers R, Osman SA, Oyama TT, Lindsley JN, Anderson S (2005) Gender hormones and the progression of experimental polycystic kidney disease. Kidney Int 68:1729\u20131739","journal-title":"Kidney Int"},{"key":"2305_CR26","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1681\/ASN.2005060601","volume":"16","author":"JH Brown","year":"2005","unstructured":"Brown JH, Bihoreau MT, Hoffmann S, Kranzlin B, Tychinskaya I, Obermuller N, Podlich D, Boehn SN, Kaisaki PJ, Megel N, Danoy P, Copley RR, Broxholme J, Witzgall R, Lathrop M, Gretz N, Gauguier D (2005) Missense mutation in sterile alpha motif of novel protein SamCystin is associated with polycystic kidney disease in (cy\/+) rat. J Am Soc Nephrol 16:3517\u20133526","journal-title":"J Am Soc Nephrol"},{"key":"2305_CR27","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","volume":"18","author":"X Song","year":"2009","unstructured":"Song X, Di Giovanni V, He N, Wang K, Ingram A, Rosenblum ND, Pei Y (2009) Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. Hum Mol Genet 18:2328\u20132343","journal-title":"Hum Mol Genet"},{"key":"2305_CR28","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5002550","volume":"72","author":"Y Tao","year":"2007","unstructured":"Tao Y, Kim J, Yin Y, Zafar I, Falk S, He Z, Faubel S, Schrier RW, Edelsterin CL (2007) VEGF receptor inhibition slows the progression of polycystic kidney disease. Kidney Int 72:1358\u20131366","journal-title":"Kidney Int"},{"key":"2305_CR29","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","volume":"16","author":"JA Forsythe","year":"1996","unstructured":"Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604\u20134613","journal-title":"Mol Cell Biol"},{"key":"2305_CR30","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2353\/ajpath.2007.060455","volume":"170","author":"WM Bernhardt","year":"2007","unstructured":"Bernhardt WM, Wiesener MS, Weidmann A, Schmitt R, Weichert W, Lechler P, Campean V, Ong AC, Willam C, Gretz N, Eckardt KU (2007) Involvement of hypoxia-inducible transcription factors in polycystic kidney disease. Am J Pathol 170:830\u2013842","journal-title":"Am J Pathol"},{"key":"2305_CR31","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1681\/ASN.2006020181","volume":"17","author":"MA Esteban","year":"2006","unstructured":"Esteban MA, Harten SK, Tran MG, Maxwell PH (2006) Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein. J Am Soc Nephrol 17:1801\u20131806","journal-title":"J Am Soc Nephrol"},{"key":"2305_CR32","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1158\/0008-5472.CAN-05-3241","volume":"66","author":"EB Rankin","year":"2006","unstructured":"Rankin EB, Tomaszewski JE, Haase VH (2006) Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. Cancer Res 66:2576\u20132583","journal-title":"Cancer Res"},{"key":"2305_CR33","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1158\/0008-5472.CAN-11-1745","volume":"71","author":"L Fu","year":"2011","unstructured":"Fu L, Wang G, Shevchuk MM, Nanus DM, Gudas LJ (2011) Generation of a mouse model of von Hippel-Lindau kidney disease leading to renal cancers by expression of a constitutively active mutant of HIF1\u03b1. Cancer Res 71:6848\u20136856","journal-title":"Cancer Res"},{"key":"2305_CR34","doi-asserted-by":"crossref","first-page":"e31034","DOI":"10.1371\/journal.pone.0031034","volume":"7","author":"RE Schietke","year":"2012","unstructured":"Schietke RE, Hackenbeck T, Tran M, G\u00fcnther R, Klanke B, Warnecke CL, Knaup KX, Shukla D, Rosenberger C, Koesters R, Bachmann S, Betz P, Schley G, Sch\u00f6del J, Willam C, Winkler T, Amann K, Eckardt KU, Maxwell P, Wiesener MS (2012) Renal tubular HIF-2\u03b1 expression requires VHL inactivation and causes fibrosis and cysts. PLoS One 7:e31034","journal-title":"PLoS One"},{"key":"2305_CR35","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1681\/ASN.2009010045","volume":"21","author":"K Madsen","year":"2010","unstructured":"Madsen K, Marcussen N, Pedersen M, Kjaersgaard G, Facemire C, Coffman TM, Jensen BL (2010) Angiotensin II promotes development of the renal microcirculation through AT1 receptors. J Am Soc Nephrol 21:448\u2013459","journal-title":"J Am Soc Nephrol"},{"key":"2305_CR36","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1097\/01.ASN.0000099374.58607.C9","volume":"14","author":"B Rizkalla","year":"2003","unstructured":"Rizkalla B, Forbes JM, Cooper ME, Cao Z (2003) Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors. J Am Soc Nephrol 14:3061\u20133071","journal-title":"J Am Soc Nephrol"},{"key":"2305_CR37","doi-asserted-by":"crossref","first-page":"F775","DOI":"10.1152\/ajprenal.00370.2003","volume":"287","author":"M Loghman-Adham","year":"2004","unstructured":"Loghman-Adham M, Soto CE, Inagami T, Cassis L (2004) The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Am J Physiol Ren Physiol 287:F775\u2013F788","journal-title":"Am J Physiol Ren Physiol"},{"key":"2305_CR38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1242\/jcs.084301","volume":"125","author":"NG Paz dela","year":"2012","unstructured":"dela Paz NG, Walshe TE, Leach LL, Saint-Geniez M, D\u2019Amore PA (2012) Role of shear-stress-induced VEGF expression in endothelial cell survival. J Cell Sci 125:831\u2013843","journal-title":"J Cell Sci"},{"key":"2305_CR39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jcp.21229","volume":"214","author":"W Goettsch","year":"2008","unstructured":"Goettsch W, Gryczka C, Korff T, Ernst E, Goettsch C, Seebach J, Schnittler HJ, Augustin HG, Morawietz H (2008) Flow-dependent regulation of angiopoietin-2. J Cell Physiol 214:491\u2013503","journal-title":"J Cell Physiol"},{"key":"2305_CR40","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/ki.2010.355","volume":"79","author":"BY Reed","year":"2011","unstructured":"Reed BY, Masoumi A, Elhassan E, McFann K, Cadnapaphornchai MA, Maahs DM, Snell-Bergeon JK, Schrier RW (2011) Angiogenic growth factors correlate with disease severity in young patients with autosomal dominant polycystic kidney disease. Kidney Int 79:128\u2013134","journal-title":"Kidney Int"},{"key":"2305_CR41","doi-asserted-by":"crossref","first-page":"F905","DOI":"10.1152\/ajprenal.2000.278.6.F905","volume":"278","author":"J Kanellis","year":"2000","unstructured":"Kanellis J, Fraser S, Katerelos M, Power DA (2000) Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells. Am J Physiol Ren Physiol 278:F905\u2013F915","journal-title":"Am J Physiol Ren Physiol"},{"key":"2305_CR42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1523-1755.2005.67101.x","volume":"67","author":"G Villegas","year":"2005","unstructured":"Villegas G, Lange-Sperandio B, Tufro A (2005) Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int 67:449\u2013457","journal-title":"Kidney Int"},{"key":"2305_CR43","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.2353\/ajpath.2009.080792","volume":"175","author":"S Hakroush","year":"2009","unstructured":"Hakroush S, Moeller MJ, Theilig F, Kaissling B, Sijmonsma TP, Jugold M, Akeson AL, Traykova-Brauch M, Hosser H, Hahnel B, Grone HJ, Koesters R, Kriz W (2009) Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation and glomerular disease. Am J Pathol 175:1883\u20131895","journal-title":"Am J Pathol"},{"key":"2305_CR44","first-page":"893","volume":"31","author":"KA Rees","year":"2007","unstructured":"Rees KA, Singh H, Brindle NP (2007) The receptor tyrosine kinase Tie1 is expressed and activated in epithelial tumour cell lines. Int J Oncol 31:893\u2013897","journal-title":"Int J Oncol"},{"key":"2305_CR45","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1165\/rcmb.2009-0330OC","volume":"44","author":"TO Makinde","year":"2011","unstructured":"Makinde TO, Agrawal DK (2011) Increased expression of angiopoietins and Tie2 in the lungs of chronic asthmatic mice. Am J Respir Cell Mol Biol 44:384\u2013393","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2305_CR46","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1210\/jc.86.6.2709","volume":"86","author":"JD Ramsden","year":"2001","unstructured":"Ramsden JD, Cocks HC, Shams M, Niijar S, Watkinson JC, Sheppard MC, Ahmed A, Eggo MC (2001) Tie-2 is expressed on thyroid follicular cells, is increased in goiter, and is regulated by thyrotropin through cyclic adenosine 3\u20195\u2019-monophosphate. J Clin Endocrinol Metab 86:2709\u20132716","journal-title":"J Clin Endocrinol Metab"},{"key":"2305_CR47","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bbadis.2010.11.005","volume":"1812","author":"DP Wallace","year":"2011","unstructured":"Wallace DP (2011) Cyclic AMP-mediated cyst expansion. Biochim Biophys Acta 1812:1291\u20131300","journal-title":"Biochim Biophys Acta"},{"key":"2305_CR48","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cellbi.2005.03.006","volume":"29","author":"SC Teilmann","year":"2005","unstructured":"Teilmann SC, Christensen ST (2005) Localization of the angiopoietin receptors Tie-1 and Tie-2 on the primary cilia in the female reproductive organs. Cell Biol Int 29:340\u2013346","journal-title":"Cell Biol Int"},{"key":"2305_CR49","doi-asserted-by":"crossref","first-page":"F773","DOI":"10.1152\/ajprenal.00058.2011","volume":"301","author":"S Raina","year":"2011","unstructured":"Raina S, Honer M, Kramer SD, Liu Y, Wang X, Segerer S, Wuthrich RP, Serra AL (2011) Anti-VEGF antibody treatment accelerates polycystic kidney disease. Am J Physiol Ren Physiol 301:F773\u2013F783","journal-title":"Am J Physiol Ren Physiol"},{"key":"2305_CR50","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE (2008) VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358:1129\u20131136","journal-title":"N Engl J Med"},{"key":"2305_CR51","doi-asserted-by":"crossref","first-page":"12605","DOI":"10.1074\/jbc.C300012200","volume":"278","author":"H Sugimoto","year":"2003","unstructured":"Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, Kalluri R (2003) Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 278:12605\u201312608","journal-title":"J Biol Chem"},{"key":"2305_CR52","doi-asserted-by":"crossref","first-page":"C419","DOI":"10.1152\/ajpcell.00038.2007","volume":"293","author":"CR Amura","year":"2007","unstructured":"Amura CR, Brodsky KS, Groff R, Gattone VH, Voelkel NF, Doctor RB (2007) VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25\/-) mice. Am J Physiol Cell Physiol 293:C419\u2013C428","journal-title":"Am J Physiol Cell Physiol"},{"key":"2305_CR53","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ki.2008.179","volume":"74","author":"DA Long","year":"2008","unstructured":"Long DA, Price KL, Ioffe E, Gannon CM, Gnudi L, White KE, Yancopoulos GD, Rudge JS, Woolf AS (2008) Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury. Kidney Int 74:300\u2013309","journal-title":"Kidney Int"},{"key":"2305_CR54","doi-asserted-by":"crossref","first-page":"F145","DOI":"10.1152\/ajprenal.90430.2008","volume":"296","author":"W Mu","year":"2009","unstructured":"Mu W, Long DA, Ouyang X, Agarwal A, Cruz PE, Roncal CA, Nakagawa T, Yu X, Hauswirth WW, Johnson RJ (2009) Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism. Am J Physiol Ren Physiol 296:F145\u2013F152","journal-title":"Am J Physiol Ren Physiol"},{"key":"2305_CR55","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1089\/hum.2007.135","volume":"19","author":"MJ Mellon","year":"2008","unstructured":"Mellon MJ, Bae KH, Steding CE, Jimenez JA, Kao C, Gardner TA (2008) Suppression of renal cell carcinoma growth and metastasis with sustained antiangiogenic gene therapy. Hum Gene Ther 19:487\u2013495","journal-title":"Hum Gene Ther"},{"key":"2305_CR56","doi-asserted-by":"crossref","first-page":"e31120","DOI":"10.1371\/journal.pone.0031120","volume":"7","author":"JS Carew","year":"2012","unstructured":"Carew JS, Esquvel JA 2nd, Espitia CM, Schultes CM, Milbaier M, Lewis JD, Janssen B, Giles FJ, Nawrocki ST (2012) ELR5104444 inhibits tumor growth and angiogenesis by abrogating HIF activity and disrupting microtubules in renal cell carcimona. PLoS One 7:e31120","journal-title":"PLoS One"},{"key":"2305_CR57","doi-asserted-by":"crossref","first-page":"27055","DOI":"10.1074\/jbc.M112.364414","volume":"287","author":"KJ Yin","year":"2012","unstructured":"Yin KJ, Olsen K, Hamblin M, Zhang J, Schwendeman SP, Chen YE (2012) Vascular endothelial cell-specific microRNA-15a inhibits angiogenesis in himblimb ischemia. J Biol Chem 287:27055\u201327064","journal-title":"J Biol Chem"},{"key":"2305_CR58","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1681\/ASN.2006090994","volume":"18","author":"MY Chang","year":"2007","unstructured":"Chang MY, Parker E, El Nahas M, Haylor JL, Ong AC (2007) Endothelin B receptor blockade accelerates disease progression in a murine model of autosomal dominant polycystic kidney disease. J Am Soc Nephrol 18:560\u2013569","journal-title":"J Am Soc Nephrol"},{"key":"2305_CR59","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1681\/ASN.V971169","volume":"9","author":"B Hocher","year":"1998","unstructured":"Hocher B, Zart R, Schwarz A, Vogt V, Braun C, Thone-Reineke C, Braun N, Neumayer HH, Koppenhagen K, Bauer C, Rohmeiss P (1998) Renal endothelin system in polycystic kidney disease. J Am Soc Nephrol 9:1169\u20131177","journal-title":"J Am Soc Nephrol"},{"key":"2305_CR60","first-page":"985","volume":"231","author":"SD McCarter","year":"2006","unstructured":"McCarter SD, Lai PF, Suen RS, Stewart DJ (2006) Regulation of endothelin-1 by angiopoietin-1: implications for inflammation. Exp Biol Med 231:985\u2013991","journal-title":"Exp Biol Med"},{"key":"2305_CR61","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/ki.2008.661","volume":"75","author":"I Sakamoto","year":"2009","unstructured":"Sakamoto I, Ito Y, Mizuno M, Suzuki Y, Sawai A, Tanaka A, Maruyama S, Takei Y, Yuzawa Y, Matsuo S (2009) Lymphatic vessels develop during tubulointerstitial fibrosis. Kidney Int 75:828\u2013838","journal-title":"Kidney Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-012-2305-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-012-2305-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-012-2305-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T09:56:57Z","timestamp":1643450217000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-012-2305-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,19]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["2305"],"URL":"https:\/\/doi.org\/10.1007\/s00467-012-2305-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,19]]}}}